Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $799.9500 (-2.76%) ($799.9500 - $818.9400) on Thu. Nov. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.19% (three month average) | RSI | 47 | Latest Price | $799.9500(-2.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(59%) IBB(50%) DIA(47%) SPY(47%) SPLV(46%) | Factors Impacting REGN price | REGN will decline at least -0.595% in a week (0% probabilities). VXX(-46%) VIXM(-29%) TBT(-21%) UNG(-16%) SKYY(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.595% (StdDev 1.19%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $809.31 | 5 Day Moving Average | $820.45(-2.5%) | 10 Day Moving Average | $805.37(-0.67%) | 20 Day Moving Average | $809.31(-1.16%) | To recent high | -5.4% | To recent low | 3.2% | Market Cap | $84.818b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |